367 related articles for article (PubMed ID: 6298281)
21. Sex difference in the effect of aspirin on rat platelet aggregation and arachidonic acid metabolism.
Morikawa M; Kojima T; Inoue M; Tsuboi M
Jpn J Pharmacol; 1985 Apr; 37(4):317-23. PubMed ID: 3925205
[TBL] [Abstract][Full Text] [Related]
22. Human pharmacology of naproxen sodium.
Capone ML; Tacconelli S; Sciulli MG; Anzellotti P; Di Francesco L; Merciaro G; Di Gregorio P; Patrignani P
J Pharmacol Exp Ther; 2007 Aug; 322(2):453-60. PubMed ID: 17473175
[TBL] [Abstract][Full Text] [Related]
23. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
Mevkh AT; Basevich VV; Varfolomeev SD
Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
[TBL] [Abstract][Full Text] [Related]
24. Epinephrine potentiation of arachidonate-induced aggregation of cyclooxygenase-deficient platelets.
Rao GH; White JG
Am J Hematol; 1981 Dec; 11(4):355-66. PubMed ID: 7331991
[TBL] [Abstract][Full Text] [Related]
25. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
[TBL] [Abstract][Full Text] [Related]
26. Thrombin pretreatment of human platelets impairs thromboxane A2 synthesis from endogenous precursors in the presence of normal cyclooxygenase activity.
Reimers HJ; Scharf RE; Baker RK
Blood; 1984 Apr; 63(4):858-65. PubMed ID: 6231068
[TBL] [Abstract][Full Text] [Related]
27. Antiplatelet effect by p-cresol, a uremic and environmental toxicant, is related to inhibition of reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Chang MC; Wang TM; Yeung SY; Jeng PY; Liao CH; Lin TY; Lin CC; Lin BR; Jeng JH
Atherosclerosis; 2011 Dec; 219(2):559-65. PubMed ID: 21993412
[TBL] [Abstract][Full Text] [Related]
28. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.
Burns GB; Dodge JA
Agents Actions; 1984 Jan; 14(1):102-8. PubMed ID: 6322546
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease.
Lordkipanidzé M; Pharand C; Schampaert E; Palisaitis DA; Diodati JG
Int J Cardiol; 2011 Jul; 150(1):39-44. PubMed ID: 20207433
[TBL] [Abstract][Full Text] [Related]
30. Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase.
Lagarde M; Byron PA; Vargaftig BB; Dechavanne M
Br J Haematol; 1978 Feb; 38(2):251-66. PubMed ID: 205238
[TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets.
Rocca B; Secchiero P; Ciabattoni G; Ranelletti FO; Catani L; Guidotti L; Melloni E; Maggiano N; Zauli G; Patrono C
Proc Natl Acad Sci U S A; 2002 May; 99(11):7634-9. PubMed ID: 12032335
[TBL] [Abstract][Full Text] [Related]
32. The role of prostaglandins in platelet function.
Burch JW; Majerus PW
Semin Hematol; 1979 Jul; 16(3):196-207. PubMed ID: 113883
[No Abstract] [Full Text] [Related]
33. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
[TBL] [Abstract][Full Text] [Related]
34. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
35. Cyclooxygenase-1 and -2 of endothelial cells utilize exogenous or endogenous arachidonic acid for transcellular production of thromboxane.
Karim S; Habib A; Lévy-Toledano S; Maclouf J
J Biol Chem; 1996 May; 271(20):12042-8. PubMed ID: 8662657
[TBL] [Abstract][Full Text] [Related]
36. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2.
Caughey GE; Cleland LG; Penglis PS; Gamble JR; James MJ
J Immunol; 2001 Sep; 167(5):2831-8. PubMed ID: 11509629
[TBL] [Abstract][Full Text] [Related]
37. Laboratory effect on platelet activity within 24 h of the first 300-mg oral dose of aspirin given in hospital during the acute phase of ischemic cerebral events.
Richard S; Toussaint-Hacquard M; Fay R; Lacour JC; Ducrocq X; Lecompte T
Cerebrovasc Dis; 2012; 33(6):574-8. PubMed ID: 22710855
[TBL] [Abstract][Full Text] [Related]
38. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor.
Carmo LG; Hatmi M; Rotilio D; Vargaftig BB
Br J Pharmacol; 1985 Aug; 85(4):849-59. PubMed ID: 2994786
[TBL] [Abstract][Full Text] [Related]
39. Platelet and blood vessel arachidonate metabolism and interactions.
Needleman P; Wyche A; Raz A
J Clin Invest; 1979 Feb; 63(2):345-9. PubMed ID: 372240
[TBL] [Abstract][Full Text] [Related]
40. COX-2 is not involved in thromboxane biosynthesis by activated human platelets.
Patrignani P; Sciulli MG; Manarini S; Santini G; Cerletti C; Evangelista V
J Physiol Pharmacol; 1999 Dec; 50(4):661-7. PubMed ID: 10639016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
